التفاصيل البيبلوغرافية
| العنوان: |
Inhibition of xanthine oxidase alleviated pancreatic necrosis via HIF-1α-regulated LDHA and NLRP3 signaling pathway in acute pancreatitis. |
| المؤلفون: |
Rong, Juan, Han, Chenxia, Huang, Yan, Wang, Yiqin, Qiu, Qi, Wang, Manjiangcuo, Wang, Shisheng, Wang, Rui, Yang, Juqin, Li, Xia, Hu, Chenggong, Chen, Zhiyao, Deng, Lihui, Huang, Wei, Xia, Qing, Du, Dan |
| المصدر: |
Acta Pharmaceutica Sinica B; Aug2024, Vol. 14 Issue 8, p3591-3604, 14p |
| مصطلحات موضوعية: |
PANCREATIC acinar cells, XANTHINE oxidase, LACTATE dehydrogenase, GENETIC engineering, PYRIN (Protein), NECROTIZING pancreatitis |
| مستخلص: |
Acute pancreatitis (AP) is a potentially fatal condition with no targeted treatment options. Although inhibiting xanthine oxidase (XO) in the treatment of AP has been studied in several experimental models and clinical trials, whether XO is a target of AP and what its the main mechanism of action is remains unclear. Here, we aimed to re-evaluate whether XO is a target aggravating AP other than merely generating reactive oxygen species that trigger AP. We first revealed that XO expression and enzyme activity were significantly elevated in the serum and pancreas of necrotizing AP models. We also found that allopurinol and febuxostat, as purine-like and non-purine XO inhibitors, respectively, exhibited protective effects against pancreatic acinar cell death in vitro and pancreatic damage in vivo at different doses and treatment time points. Moreover, we observed that conditional Xdh overexpression aggravated pancreatic necrosis and severity. Further mechanism analysis showed that XO inhibition restored the hypoxia-inducible factor 1-alpha (HIF-1 α)-regulated lactate dehydrogenase A (LDHA) and NOD-like receptor family pyrin domain containing 3 (NLRP3) signaling pathways and reduced the enrichment of 13C 6 -glucose to 13C 3 -lactate. Lastly, we observed that clinical circulatory XO activity was significantly elevated in severe cases and correlated with C-reactive protein levels, while pancreatic XO and urate were also increased in severe AP patients. These results together indicated that proper inhibition of XO might be a promising therapeutic strategy for alleviating pancreatic necrosis and preventing progression of severe AP by downregulating HIF-1 α -mediated LDHA and NLRP3 signaling pathways. XO was enormously increased in necrotic murine models and severe patients of acute pancreatitis, pharmacological and genetic intervention of XO significantly affected disease severity via HIF-1 α -regulated LDHA and NLRP3 pathway. [Display omitted] [ABSTRACT FROM AUTHOR] |
|
Copyright of Acta Pharmaceutica Sinica B is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Supplemental Index |
Full Text Finder